Figure 1. The outcomes of high-risk APL patients.
Figure 1. The outcomes of high-risk APL patients. The cumulative incidence rate of hematologic CR and CMR (A), and EFS and OS (B) for high-risk APL patients treated with oral arsenic and ATRA.

The cumulative incidence rate of hematologic CR and CMR (A), and EFS and OS (B) for high-risk APL patients treated with oral arsenic and ATRA.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal